Norepinephrine significantly increased the iodine concentration of brown adipose tissue compared to saline (28.75 vs. 7.49 mg/cm3, p < 0.001) on contrast-enhanced spectral CT.
Does norepinephrine stimulation increase the vascular response in brown adipose tissue compared to white adipose tissue as measured by spectral CT in rats?
Spectral CT can non-invasively characterize and differentiate brown from white adipose tissue by quantifying fat concentration and norepinephrine-induced vascular responses.
Absolute Event Rate: 28.75% vs 7.49%
p-value: p=<0.001
OBJECTIVE: The purpose of the study was to non-invasively characterize and discriminate brown adipose tissue (BAT) from white adipose tissue (WAT) in rats using spectral computed tomography (CT) with histological validation. MATERIALS AND METHODS: , non-enhanced spectral CT scan was performed on 24 rats, and fat concentrations of BAT and WAT were measured. The rats were randomized to receive intraperitoneal treatment with norepinephrine (NE) (n = 12) or saline (n = 12). Non-enhanced and enhanced spectral CT scans were performed after treatment to measure the elevation of iodine in BAT and WAT. The BAT/aorta and WAT/aorta ratios were calculated and compared, after which isolated BAT and WAT samples were subjected to histological and uncoupling protein 1 (UCP1) analyses. RESULTS: < 0.001). Histological and UCP1 expression analyses supported the spectral CT imaging results. CONCLUSION: The study consolidates spectral CT as a new approach for non-invasive imaging of BAT and WAT. Quantitative analyses of BAT and WAT by spectral CT revealed different characteristics and pharmacologic activations in the two types of adipose tissue.
Peng et al. (Fri,) conducted a other in Healthy (evaluating brown vs white adipose tissue) (n=30). Norepinephrine vs. Saline was evaluated on Iodine concentration of brown adipose tissue (BAT) (p=<0.001). Norepinephrine significantly increased the iodine concentration of brown adipose tissue compared to saline (28.75 vs. 7.49 mg/cm3, p < 0.001) on contrast-enhanced spectral CT.